The Food and Drug Administration has designated a drug made by Teva Pharmaceutical Industries as an orphan drug, the company said.
The Food and Drug Administration has approved a new formulation of a cancer drug made by Teva Pharmaceutical Industries, Teva said Tuesday.
U.S.-based drug maker Perrigo Co. will buy Ireland's Elan Corp. for $8.6 billion, the companies said.
The Food and Drug Administration has approved a new treatment for multiple sclerosis made by Biogen Idec, the agency said.
A privately owned drug maker in New York is offering $6.5 billion for Irish drug maker Elan Corp., but hasn't heard back from it, according to published reports.
Elan will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.
Biogen Idec is seeking Food and Drug Administration approval for a hemophilia drug that it called the first of its kind.
An experimental drug for Lou Gehrig's disease made by Biogen Idec has failed in a late-stage clinical trial, the drug maker said.
Drug maker Biogen Idec plans to spend up to more than $560 million to buy a company developing treatments for organ failure.
Biogen Idec has appointed a former Lenovo executive to serve as its EVP human resources.
Biogen Idec and Isis Pharmaceuticals will work together on a drug invented by Isis for spinal muscular atrophy, the two companies said.